APRE insider buying
Every open-market purchase of Aprea Therapeutics, Inc. (APRE) stock by its officers, directors and major shareholders, from SEC Form 4 filings.
Bought, last 12 months$50.12K
Insiders buying (12m)2
Purchases on record2
Last purchase filedFeb 2, 2026
In the last 12 months, 2 insiders of Aprea Therapeutics, Inc. bought $50.12K of APRE stock on the open market in 2 reported purchases. The most recent was filed on Feb 2, 2026: Gilad Oren (President/CEO, Director) bought 28,100 shares at $0.89, worth $25.01K. The largest purchase on record here is $25.11K by Duey Marc on Dec 10, 2025.
Get the next APRE insider buy on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on Telegram